Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 8638 | 8.6376 |
09:34 ET | 1550 | 8.67 |
09:36 ET | 2592 | 8.67 |
09:38 ET | 7295 | 8.64 |
09:39 ET | 2150 | 8.65 |
09:41 ET | 100 | 8.64 |
09:43 ET | 1694 | 8.695 |
09:45 ET | 1950 | 8.71 |
09:48 ET | 2600 | 8.66 |
09:50 ET | 211 | 8.65 |
09:52 ET | 675 | 8.65 |
09:54 ET | 1659 | 8.66 |
09:56 ET | 8700 | 8.58 |
09:57 ET | 695 | 8.5601 |
09:59 ET | 6897 | 8.54 |
10:01 ET | 600 | 8.56 |
10:03 ET | 717 | 8.535 |
10:06 ET | 700 | 8.54 |
10:08 ET | 100 | 8.541 |
10:10 ET | 596 | 8.54 |
10:14 ET | 700 | 8.56 |
10:15 ET | 1342 | 8.52 |
10:17 ET | 1376 | 8.54 |
10:19 ET | 200 | 8.53 |
10:21 ET | 100 | 8.53 |
10:24 ET | 250 | 8.53 |
10:26 ET | 3088 | 8.5293 |
10:30 ET | 3556 | 8.525 |
10:32 ET | 1627 | 8.54 |
10:35 ET | 1101 | 8.54 |
10:37 ET | 100 | 8.51 |
10:39 ET | 6542 | 8.48 |
10:42 ET | 3604 | 8.5 |
10:44 ET | 860 | 8.51 |
10:46 ET | 100 | 8.52 |
10:50 ET | 349 | 8.52 |
10:51 ET | 300 | 8.51 |
10:53 ET | 300 | 8.51 |
10:55 ET | 718 | 8.51 |
10:57 ET | 400 | 8.51 |
11:00 ET | 100 | 8.51 |
11:02 ET | 2300 | 8.48 |
11:04 ET | 1250 | 8.49 |
11:06 ET | 832 | 8.5 |
11:08 ET | 700 | 8.49 |
11:09 ET | 6409 | 8.48 |
11:11 ET | 2008 | 8.47 |
11:13 ET | 2434 | 8.48 |
11:15 ET | 100 | 8.48 |
11:18 ET | 600 | 8.48 |
11:20 ET | 1100 | 8.48 |
11:22 ET | 473 | 8.47 |
11:26 ET | 300 | 8.46 |
11:27 ET | 931 | 8.46 |
11:29 ET | 700 | 8.4634 |
11:31 ET | 200 | 8.47 |
11:36 ET | 1350 | 8.48 |
11:38 ET | 689 | 8.4747 |
11:40 ET | 518 | 8.48 |
11:42 ET | 100 | 8.49 |
11:44 ET | 300 | 8.48 |
11:45 ET | 200 | 8.485 |
11:47 ET | 2357 | 8.48 |
11:49 ET | 3980 | 8.49 |
11:51 ET | 4021 | 8.49 |
11:54 ET | 200 | 8.49 |
11:56 ET | 2205 | 8.51 |
11:58 ET | 3027 | 8.47 |
12:00 ET | 5689 | 8.51 |
12:02 ET | 690 | 8.49 |
12:03 ET | 928 | 8.45 |
12:05 ET | 200 | 8.46 |
12:07 ET | 300 | 8.47 |
12:09 ET | 1152 | 8.47 |
12:12 ET | 1281 | 8.45 |
12:14 ET | 501 | 8.459 |
12:16 ET | 1100 | 8.46 |
12:18 ET | 200 | 8.46 |
12:20 ET | 2598 | 8.45 |
12:21 ET | 1100 | 8.45 |
12:23 ET | 100 | 8.44 |
12:25 ET | 200 | 8.44 |
12:27 ET | 1621 | 8.44 |
12:30 ET | 1200 | 8.43 |
12:32 ET | 1499 | 8.41 |
12:34 ET | 4326 | 8.4 |
12:36 ET | 1199 | 8.41 |
12:38 ET | 2599 | 8.41 |
12:39 ET | 657 | 8.4 |
12:41 ET | 7595 | 8.41 |
12:43 ET | 100 | 8.4 |
12:45 ET | 800 | 8.415 |
12:48 ET | 2117 | 8.43 |
12:50 ET | 318 | 8.4279 |
12:52 ET | 1010 | 8.43 |
12:54 ET | 750 | 8.425 |
12:56 ET | 1412 | 8.44 |
12:57 ET | 400 | 8.43 |
12:59 ET | 1977 | 8.445 |
01:01 ET | 2898 | 8.45 |
01:03 ET | 1480 | 8.47 |
01:06 ET | 300 | 8.47 |
01:08 ET | 2355 | 8.455 |
01:10 ET | 600 | 8.45 |
01:12 ET | 1318 | 8.46 |
01:14 ET | 2655 | 8.46 |
01:15 ET | 2742 | 8.44 |
01:17 ET | 2132 | 8.42 |
01:19 ET | 1250 | 8.42 |
01:21 ET | 950 | 8.42 |
01:24 ET | 3694 | 8.415 |
01:26 ET | 1077 | 8.42 |
01:28 ET | 100 | 8.42 |
01:30 ET | 1093 | 8.45 |
01:32 ET | 1853 | 8.45 |
01:33 ET | 100 | 8.45 |
01:35 ET | 400 | 8.455 |
01:37 ET | 200 | 8.46 |
01:39 ET | 1976 | 8.47 |
01:42 ET | 800 | 8.485 |
01:44 ET | 893 | 8.51 |
01:46 ET | 3715 | 8.515 |
01:48 ET | 174 | 8.5 |
01:50 ET | 400 | 8.515 |
01:51 ET | 1104 | 8.51 |
01:53 ET | 100 | 8.5 |
01:55 ET | 440 | 8.505 |
01:57 ET | 1437 | 8.5 |
02:00 ET | 400 | 8.505 |
02:02 ET | 100 | 8.5 |
02:04 ET | 775 | 8.505 |
02:06 ET | 7713 | 8.4601 |
02:08 ET | 2524 | 8.48 |
02:09 ET | 300 | 8.48 |
02:11 ET | 744 | 8.49 |
02:13 ET | 1600 | 8.5 |
02:15 ET | 600 | 8.5 |
02:18 ET | 488 | 8.5 |
02:20 ET | 700 | 8.51 |
02:22 ET | 1357 | 8.51 |
02:24 ET | 400 | 8.51 |
02:26 ET | 1792 | 8.51 |
02:27 ET | 731 | 8.51 |
02:29 ET | 2614 | 8.49 |
02:31 ET | 100 | 8.49 |
02:33 ET | 300 | 8.48 |
02:36 ET | 2554 | 8.49 |
02:38 ET | 962 | 8.5 |
02:40 ET | 1226 | 8.49 |
02:42 ET | 200 | 8.49 |
02:44 ET | 1000 | 8.51 |
02:45 ET | 950 | 8.51 |
02:47 ET | 500 | 8.49 |
02:49 ET | 400 | 8.51 |
02:51 ET | 875 | 8.51 |
02:54 ET | 1800 | 8.5 |
02:56 ET | 4720 | 8.51 |
02:58 ET | 4610 | 8.52 |
03:00 ET | 3248 | 8.52 |
03:02 ET | 100 | 8.51 |
03:03 ET | 374 | 8.51 |
03:05 ET | 1600 | 8.515 |
03:07 ET | 960 | 8.52 |
03:09 ET | 3894 | 8.56 |
03:12 ET | 900 | 8.56 |
03:14 ET | 4893 | 8.525 |
03:16 ET | 528 | 8.53 |
03:18 ET | 3163 | 8.54 |
03:20 ET | 225 | 8.53 |
03:21 ET | 600 | 8.53 |
03:23 ET | 100 | 8.53 |
03:25 ET | 1136 | 8.535 |
03:27 ET | 3980 | 8.525 |
03:30 ET | 2658 | 8.52 |
03:32 ET | 900 | 8.52 |
03:34 ET | 5243 | 8.52 |
03:36 ET | 1090 | 8.53 |
03:38 ET | 500 | 8.52 |
03:39 ET | 1000 | 8.525 |
03:41 ET | 4319 | 8.54 |
03:43 ET | 1099 | 8.535 |
03:45 ET | 3624 | 8.5231 |
03:48 ET | 400 | 8.525 |
03:50 ET | 3687 | 8.525 |
03:52 ET | 5073 | 8.5495 |
03:54 ET | 4404 | 8.555 |
03:56 ET | 2691 | 8.57 |
03:57 ET | 16619 | 8.53 |
03:59 ET | 30712 | 8.53 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.1x | --- |
Nurix Therapeutics Inc | 1.2B | -7.3x | --- |
Prothena Corporation PLC | 1.1B | -6.2x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -3.6x | --- |
Immatics NV | 1.2B | -11.1x | --- |
Ardelyx Inc | 1.2B | -18.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 14.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.